---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-021201"
form_type: "8-K"
ticker: "CRVO"
cik: "0001053691"
company_name: "CervoMed Inc."
filed_at: "2023-07-31T23:59:59+00:00"
generated_at: "2026-06-12T21:41:50.048600+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Diffusion Pharmaceuticals appoints Jill Davidson to board under settlement agreement

## Summary
- Jill Davidson appointed as director effective July 26, 2023, expanding board to seven members.
- Appointment made pursuant to December 2022 Settlement Agreement with LifeSci Group.
- Davidson designated as one of two Company Designees for post-merger board if EIP Pharma merger closes.
- Term expires at 2023 annual meeting or when LifeSci Group's net long position falls below 96,976 shares.
- Davidson will receive standard non-employee director compensation and enter indemnification agreement.

## SEC filing metadata
- accession: 0001437749-23-021201
- form_type: 8-K
- ticker: CRVO
- cik: 0001053691
- company_name: CervoMed Inc.
- filed_at: 2023-07-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053691/000143774923021201/0001437749-23-021201-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053691/000143774923021201/dffn20230731_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-021201
- JSON: https://secwatch.observer/filing/0001437749-23-021201.json
- Plain text: https://secwatch.observer/filing/0001437749-23-021201.txt

## Key facts
- Executive change
  Jill Davidson was appointed as director at CervoMed Inc..
  - Action: appointed
  - Role: director
  source text: Effective July 26, 2023, the Board of Directors (the “Board”) of Diffusion Pharmaceuticals Inc. (the “Company”) appointed Jill Davidson as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1053691/000143774923021201/0001437749-23-021201-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.